Showing 461 - 480 results of 1,071 for search '"B cell"', query time: 0.07s Refine Results
  1. 461

    Lymphomatoid granulomatosis with rare manifestations. Case report by Pedro Rosales Torres, Pedro León Acosta

    Published 2024-01-01
    “…Conclusions: lymphomatoid granulomatosis is a rare disease currently considered a lymphoid neoplasm associated with Epstein-Barr virus and large B cell lymphoma. It occurs in this patient accompanied by neurological injury; The diagnosis was only possible by anatomopathological studies. …”
    Get full text
    Article
  2. 462

    Immunotherapy with CAR-Modified T Cells: Toxicities and Overcoming Strategies by Shangjun Sun, He Hao, Ge Yang, Yi Zhang, Yang Fu

    Published 2018-01-01
    “…Unparalleled clinical efficacy recently demonstrated in refractory B-cell malignancy has brought this new form of adoptive immunotherapy to the center stage. …”
    Get full text
    Article
  3. 463

    Primary neurolymphomatosis presenting as foot drop: A rare case report by Neha Bakshi, Vineeta Chand, Rajiv Anand, Rajan Duggal

    Published 2024-12-01
    “…The patient was initially misdiagnosed as chronic inflammatory demyelinating polyneuropathy; however radiological assessment revealed fusiform thickening of the L5 nerve root and biopsy from the site revealed extensive infiltration by diffuse large B cell type non-Hodgkin lymphoma (NHL). High index of suspicion is vital to ensure correct diagnosis, timely treatment, and to improve patient survival.…”
    Get full text
    Article
  4. 464

    Daratumumab, Lenalidomide, and Dexamethasone (DRD), an Active Regimen in the Treatment of Immunosuppression-Associated Plasmablastic Lymphoma (PBL) in the Setting of Gorham’s Lymph... by Matthew Lee, Beth A. Martin, Haifaa Abdulhaq

    Published 2022-01-01
    “…Characterized by an aggressive course with a poor overall survival due to treatment refractoriness, plasmablastic lymphoma (PBL) is a rare variant of diffuse large cell B cell lymphoma. Gorham’s lymphangiomatosis or Gorham–Stout disease (GSD) is a rare skeletal condition of unknown etiology characterized by progressive bone loss and nonmalignant proliferation of vascular and lymphatic channels within the affected bone. …”
    Get full text
    Article
  5. 465

    Salvage Therapy for Refractory Aids-Related Primary Central Nervous System Lymphoma by Hugo Ferro, Eduardo Parino

    Published 2012-01-01
    “…A sterotactic biopsy diagnosed primary central nervous system lymphoma (diffuse large B-cell lymphoma). After two cycles of high-dose metotrexate (HD-MTX-)-based chemotherapy, the tumor progressed. …”
    Get full text
    Article
  6. 466

    The Function of T Follicular Helper Cells in the Autoimmune Liver Diseases by Lin Li, Panyang Xu, Qi Zhou, Jiancheng Xu

    Published 2020-01-01
    “…T follicular helper (TFH) cells are recognized as a subtype of T cells that are involved in the germinal center formation and B cell development. When dysregulated, TFH cells may represent an important mechanism that contributes to a heightened humoral response and autoantibody production in autoimmune liver diseases (AILDs). …”
    Get full text
    Article
  7. 467

    Undifferentiated Malignant Neoplasm Involving Parotid and Thyroid: Sampling and PAX8 Cross-Reactivity Can Obscure the Diagnosis of Lymphoma by Elizabeth W. Hubbard, Laurentia Nodit, Stuart Van Meter

    Published 2016-01-01
    “…Although PAX8 was immunoreactive and thus worrisome for anaplastic thyroid carcinoma, the tumor was eventually proven to represent PAX5 positive diffuse large B-cell lymphoma expressing cross-reactivity with polyclonal PAX8 antibody. …”
    Get full text
    Article
  8. 468

    Plasmablastic Lymphoma: A Systematic Review by Jorge J. Castillo, John L. Reagan

    Published 2011-01-01
    “…Plasmablastic lymphoma (PBL) is a very aggressive variant of diffuse large B-cell lymphoma initially described in the oral cavity of HIV-infected individuals. …”
    Get full text
    Article
  9. 469

    CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS by Ugo Testa, Francesco D'Alò, Elvira Pelosi, Germana Castelli, Giuseppe Leone

    Published 2024-01-01
    “…Chimeric antigen receptor (CAR)-T cell therapy targeting B-cell antigens, such as CD19 or CD20, is emerging as an efficacious treatment for R/R follicular lymphoma patients, particularly for those with early relapse and refractory to alkylating agents and to anti-CD20 monoclonal antibodies, resulting in a high rate of durable responses in a high proportion of patients.   …”
    Get full text
    Article
  10. 470

    Mantle Cell Lymphoma Mimicking Rectal Carcinoma by Engin Kelkitli, Hilmi Atay, Levent Yıldız, Ahmet Bektaş, Mehmet Turgut

    Published 2014-01-01
    “…Mantle cell lymphoma (MCL) is a mature B-cell non-Hodgkin lymphoma. After the (11;14) translocation was identified as its constant finding in 1992, MCL was recognized as a separate subgroup of non-Hodgkin lymphoma (NHL). …”
    Get full text
    Article
  11. 471

    State of Oral Mucosa as an Additional Symptom in the Course of Primary Amyloidosis and Multiple Myeloma Disease by Maciej R. Czerniuk, Artur Jurczyszyn, Grzegorz Charlinski

    Published 2014-01-01
    “…Multiple myeloma (myeloma multiplex (MM)) is a malignant non-Hodgkin’s lymphoma derived from B cell. Its essence is a malignant clone of plasma cells synthesizing growth of monoclonal immunoglobulin, which infiltrate the bone marrow, destroy the bone structure, and prevent the proper production of blood cells components. …”
    Get full text
    Article
  12. 472
  13. 473

    Single-Cell Transcriptome Analysis Reveals Different Immune Signatures in HPV- and HPV + Driven Human Head and Neck Squamous Cell Carcinoma by Simin Li, Yang Wang, Rui Sun, Debora Franceschi, Hongying Pan, Chenxuan Wei, Anthony Chukwunonso Ogbuehi, Bernd Lethaus, Vuk Savkovic, Sebastian Gaus, Rüdiger Zimmerer, Dirk Ziebolz, Gerhard Schmalz, Xiao Jiang

    Published 2022-01-01
    “…AREG, TGFBI, CD27, CXCR3, MS4A1, and CD19 were associated with worse overall survival in HPV-related HNSCC. Especially B-cell related pathways were revealed as particularly relevant in HPV-related HNSCC. …”
    Get full text
    Article
  14. 474

    Regulation and therapy: the role of ferroptosis in DLBCL by Yifan Wang, Yifan Wang, Zhengmei He, Zhengmei He, Xinyu Dong, Xinyu Dong, Yiming Yao, Yiming Yao, Qiuni Chen, Qiuni Chen, Yuye Shi, Yuye Shi, Yuan Deng, Yuan Deng, Quane Zhang, Quane Zhang, Liang Yu, Liang Yu, Liang Yu, Chunling Wang, Chunling Wang, Chunling Wang

    Published 2025-01-01
    “…Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of B-cell non-Hodgkin’s lymphoma (NHL), up to 30%–40% of patients will relapse and 10%–15% of patients have primary refractory disease, so exploring new treatment options is necessary. …”
    Get full text
    Article
  15. 475

    Experimental and Density Functional Theory Characteristics of Ibrutinib, a Bruton’s Kinase Inhibitor Approved for Leukemia Treatment by Ali I. Ismail

    Published 2021-01-01
    “…Ibrutinib, a Bruton’s tyrosine kinase that plays an essential role in the B-cell development and cancer cells, has been recently approved to treat chronic, lymphocytic, and other types of leukemia. …”
    Get full text
    Article
  16. 476

    Kaposi's Sarcoma-Associated Herpesvirus-Related Solid Lymphoma Involving the Heart and Brain by Jason R. Andrews, Yoon Andrew Cho-Park, Judith Ferry, Jeremy S. Abramson, Gregory K. Robbins

    Published 2011-01-01
    “…The disorders most strongly linked to KSHV are multicentric Castleman's Disease (MCD), primary effusion lymphoma, and diffuse large B-cell lymphomas. We report an unusual case of KSHV-associated lymphoma in an HIV-infected patient manifesting with myocardial and central nervous system involvement. …”
    Get full text
    Article
  17. 477

    High Resolution Comparative Genomic Hybridization Detects 7–8 Megabasepair Deletion in PCR Amplified DNA1 by Jacob Larsen, Anne Marie Ottesen, Maria Kirchhoff, Claes Lundsteen, Jørgen K. Larsen

    Published 2001-01-01
    “…Five DNA samples from B‐cell leukemias with small 11q deletions were amplified by DOP‐PCR and analysed by means of high resolution comparative genomic hybridization (HR‐CGH) for the evaluation of aberration size detection limit. …”
    Get full text
    Article
  18. 478

    Surgery in a Patient with Haemophilia A and Lymphoma by M. S. Cruz, J. Santillan, J. Lesser, J. Ortiz, L. Forzani, P. Plaza

    Published 2020-01-01
    “…Here, we describe the case of a 43-year-old man with severe haemophilia A and a diffuse large B-cell lymphoma, originally diagnosed as a haematoma, who underwent a splenectomy and several associated surgeries as part of his lymphoma treatment. …”
    Get full text
    Article
  19. 479

    Lymphocyte-Predominant Hodgkin’s Disease in Children: A Case Study and Review of the Literature by James R. Stier, Robert J. Vasquez

    Published 2015-01-01
    “…NLPHL is a relatively rare disease that is biologically distinct from classic Hodgkin lymphoma (cHL). NLPHL is a B-cell malignancy likely of germinal center origin that has an overall good prognosis and favorable response to treatment. …”
    Get full text
    Article
  20. 480